Novartis AG ADR (NVS)

Novartis AG ADR (NVS) is a Drug Manufacturers - General company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $287B; returns 1 day -3.3%, 1 week +0.3%, 1 year +14.8%.

Novartis AG (ADR) is a global pharmaceutical company focused on developing, manufacturing, and marketing innovative medicines, generics, and biosimilars. The company operates through two segments: Innovative Medicines (patent-protected prescription medicines) and Sandoz (generic pharmaceuticals and biosimilars).

Groups NVS belongs to

• Dividend Payers
• Healthcare
• Buying Back Stock
• 25-Year Dividend Payers
• Pharmaceuticals
• Biotechnology
• Oncology
• Breast Cancer Treatment
• Immunotherapy
• Neuroscience
• Cardiovascular Therapies
• Life Sciences
• Biopharmaceutical
• Commercial Stage
• Generics

NVS financial model: income statement, cash flow and balance sheet